BIBA Publishing

NeuroLogica Corporation, a provider of pioneering portable imaging equipment in CT and SPECT, recently announced its expansion into the Chinese medical device market with the approval of the company‰Ûªs life saving CereTom portable CT Scanner by the Chinese State Food and Drug Administration (FDA).

In the last edition of Interventional News, there is an article written by the journalist who covered the event under what I find is a regrettable headline which declared that ‰ÛÏCACVS delegates say CAS is dead‰Û. Whilst I accept the freedom of a journalist to write it as they see it, this does not mean that I personally agree with everything they write

DePuy Spine has recently announced the launch of Healos Fx injectable bone graft replacement (Healos Fx), the company’s first bone graft solution designed specifically for minimally invasive spine surgery (MIS).

Lowell S Kabnick, in his article on the RECOVERY trial, says that the 12W of power used to achieve the target LEED, and use of bare-tipped fibres contributed to the trial’s results.

Lowell S Kabnick, in his article on the RECOVERY trial, says that the 12W of power used to achieve the target LEED, and use of bare-tipped fibres contributed to the trial’s results.

Swedish image enhancing software can contribute to cutting radiation induced cancers

Latest products in its Voxar 3D advanced visualization product line will add clinical value to PACS in packages that are easy to implement and support .

Sonablate is a state of the art High Intensity Focused Ultrasound (HIFU) instrument used for the trans-rectal ablation of tumours of the prostate gland.

Miraculous results in some cases cause Turin radiologists to dub the treatment the "Lazarus effect".

A team of two interventional radiologists, one nurse, one assistant, and one driver take a mobile unit performing uterine fibroid embolizations (UFE), to female patients in Sao Paulo with low incomes, says Dr Nestor Kisilevzky.

Endovascular simulation has proved its efficacy, says Steve Dawson, Massachusetts General Hospital, USA

The treatment of mitral regurgitation using the MitraClip system has demonstrated success in the first UK patients to undergo the procedure

The penetration rate was measured at 51.6% in Western Europe: this represents the fifth consecutive increase since the third quarter 2007

Aquilion/Premium is a scalable, upgradable platform designed to maintain the highest level of performance.

Saudi Arabia‰Ûªs King Faisal Specialist Hospital & Research Centre will become region‰Ûªs first to treat cancer patients with next-generation radiation therapy solution.

Medtronic launch THRIVE study to assess aneurysm-related mortality at five years

Ongoing research in ozone treatment for herniated discs shows outcomes similar to surgery, and has researchers predicting that the minimally-invasive treatment could soon become standard in the USA

Drainage of tubo-ovarian abscesses diminishes need for salpinto-oophorectomy, according to a new study

Tony Nicholson says current attitudes towards subspecialisation leave interventional radiology stuck in the 20th century

Rationale and preliminary results of an experimental endovascular treatment for multiple sclerosis are presented at the CX Symposium

Five-year study shows significant mortality benefit with minimally-invasive procedure

Recent FDA 510(k) clearance adds long percutaneous transluminal angioplasty balloons to Invatec‰Ûªs balloon catheter line

Results of the RECOVERY trial show short-term outcomes for radiofrequency ablation device are superior to laser therapy

Results of the RECOVERY trial show short-term outcomes for radiofrequency ablation device are superior to laser therapy

US phlebologists are warned to seek advice on the use of compounded agents not approved by the FDA but commercially available, and the use of foam sclerosants

Frans Moll warns against underestimating the forces within the body that cause arteries to move and stretch

Hybrid procedures should be developed to enable endovascular repair of the aorta in one procedure, says Joseph Coselli

When comparing computed tomography angiography (CTA) and magnetic resonance angiography (MRA) for occlusive peripheral artery disease (PAD), Seth Toomay highlighted that interventions planned with CTA or MRA are both successful.

Retrievable inferior vena cava filter is found to be safe and effective in protecting patients at risk of pulmonary embolism

Sumaira MacDonald says that the EVA 3-S trial has demonstrated the world‰Ûªs first reverse learning curve, and that carotid artery stenting can only get better

Comparison by interventional radiologists shows no difference in patency of arteriovenous fistulas between young and old

The UK‰Ûªs NCCHTA is to become the NETSCC, HTA, from April 2009

UK-based ClearStream Technologies wins FDA Approval for new line of catheters

Research has uncovered a significant association between varicose veins and right-to-left shunt

The potential of 3D and functional imaging is, as yet, unrealised in vascular surgery, says Joachim Wildberger

Ongoing research shows elective repair for abdominal aortic aneurysms is on the rise in the USA, yet total related deaths continue to decline

Definiens is all set to launch their first CAD application, LymphExpert, at the European Congress of Radiology in Vienna which will be held from 6-10 March.

The UK regulatory body delivers delayed appraisal of endovascular treatment of abdominal aortic aneurysms

Final results of the RISC study suggest time limit to reduce complications in carotid artery stenting procedures

LifeStent FlexStar and FlexStar XL vascular stent systems receive US pre-market approval

LifeStent FlexStar and FlexStar XL vascular stent systems receive US pre-market approval

CoAxia‰Ûªs double balloon catheter increases blood flow to the brain and potentially reduce the damage caused by stroke.

Clark, Johnston, and Haskal demonstrate radiofrequency ablation technology platforms on bovine liver during the Symposium on Clinical Interventional Oncology.

The current prognosis of critical limb ischaemia is still very poor and amputation rates continue to increase across Europe despite advances in recent years.

Latest BASIL trial data show benefit for bypass surgery in patients who survive for two years after intervention.

An inaugural meeting of the ilegx initiative was launched at Imperial College at the weekend of 25‰ÛÒ26 October 2008. The initiative took place under the organisation of BIBA Conferences, which runs the Charing Cross Symposium series. By Roger Greenhalgh

Document containing demographics, treatment modes and outcomes of more than 84,000 from ten countries who underwent treatment for abdominal aortic aneurysms or carotid reconstruction was released at the ESVS 2008 meeting.

The Thunder trial and the guided re-shaping technology were presented at the TCT conference, in October 2008.

The current prognosis of critical limb ischaemia is still very poor and amputation rates continue to increase across Europe despite advances in recent years.

Latest BASIL trial data show benefit for bypass surgery in patients who survive for two years after intervention.

Document containing demographics, treatment modes and outcomes of more than 84,000 from ten countries who underwent treatment for abdominal aortic aneurysms or carotid reconstruction was released at the ESVS 2008 meeting.

The Thunder trial and the guided re-shaping technology were presented at the TCT conference, in October 2008.

Dr Nick Cheshire, Imperial College, London, UK, presented early data on the Hansen Robotic System (Sensei) at the VEITHsymposium 2008, and explained that intuitive robotic catheter systems may help to overcome the limitations of standard catheter technology.

A recent economic analysis of elective endovascular aneurysm repair (EVAR) in high-risk patients suggests that this approach is a cost effective strategy compared to open surgery repair (OSR).

At the recent VEITHsymposium, New York, Dr Koen Deloose, Belgium, presented the 12-month results from the MELOPEE trial, a European, prospective, multi-centre study that aimed to evaluate clinical performance and primary patency of the LifeStent (Bard) in symptomatic lesions of the popliteal artery

In a head-to-head comparison of the S.M.A.R.T. Control Nitinol Stent (Cordis) with the Luminexx 6F Stent (Bard) for the treatment of long TASC C and D superficial femoral artery (SFA) lesions, more fractures in total and significantly more fractures of the potentially clinically relevant Types III and IV were observed in the Luminexx group.

In an intensive ‰Û÷Special Session‰Ûª taking place at CIRSE meeting 2008, four prominent interventional radiologists discussed their views on how to promote interventional radiology (IR) to patients and referring physicians according to their respective therapy areas.

0

0

0

0

Over the last two decades, the management of high-risk cirrhotic patients has developed significantly, with advances in pharmacologic, endoscopic and interventional radiologic treatment options. Since its introduction over a decade ago, the transjugular intrahepatic portosystemic shunt (TIPS) placement has become a fundamental treatment option.

The Society of Interventional Radiology (SIR) meeting will take place in early March in San Diego, CA, and will be more ‰ÛÏinteractive and practical‰Û
than previous years, according to Professor Kieran Murphy, Toronto, Canada, who is responsible for the Scientific Programme

Infrapopliteal disease is the most frequent cause of major amputations and this is also one of the vascular regions where currently some of the most exciting endovascular developments emerge. At the TCT meeting, held in Washington, DC, in October 2008, new approaches to infrapopliteal management were clearly given particular attention.

The three-year outcomes from the Belgian Absolute Trial assessing the safety and performance of the Absolute Self Expandable Nitinol Stent (Abbott Vascular) for the treatment of atherosclerotic lesions of the superficial femoral artery (SFA), showed that the three year primary patency rate was achieved in 77.7% of patients, and limb salvage was 100%. A 1% fracture rate was demonstrated after one year.

According to the 24-month results from the Xpert-BTK Study, the Xpert nitinol self-expanding below-the-knee (BTK) stent (Abbott Vascular) is an efficient tool for the treatment of BTK lesions.

Drs John Arnold and Anne Roberts, comment about the use of the term, no longer included in the American Society of Anesthesiologists standards.

Professor Johannes Lammer, distinguished Interventional Radiologist at the University Hospital in Vienna, Austria, was awarded the honorary membership of the British Society of Interventional Radiology (BSIR) at its yearly meeting in November 2008 in Manchester, UK.

At the CIRSE meeting 2008, held in Copenhagen, Denmark, Professors Johannes Lammer, Anthony Watkinson, and Riccardo Lencioni presented new data supporting the use of Biocompatibles‰Ûª PRECISION TACE with DC Bead (DC Bead loaded with doxorubicin) for the treatment of hepatocellular carcinoma (HCC). The multi-centre study compared drug-eluting beads (DEB) with conventional transarterial chemoembolization (cTACE).

After the Vienna ABSOLUTE trial RESILIENT is the only randomised controlled trial to report long-term results comparing primary stenting of the superficial femoral artery (SFA) and angioplasty.

Professor Ziv J Haskal MD, Vice Chair and Chief of Vascular and Interventional Radiology at the University of Maryland, Baltimore, US

In patients with Mild to Moderate Intermittent Claudication, percutaneous transluminal angioplasty is of adjuvant benefit to smoking cessation, best medical treatment and supervised exercise.

In patients with Mild to Moderate Intermittent Claudication, percutaneous transluminal angioplasty is of adjuvant benefit to smoking cessation, best medical treatment and supervised exercise.

Interventional News speaks to Dr Ziv J Haskal about his proudest professional moments, the challenges facing interventional radiology, and his need for speed.

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Interventional News speaks to Dr Ziv J Haskal about his proudest professional moments, the challenges facing interventional radiology, and his need for speed.